Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Related Posts
CVS Health CEO Karen Lynch steps down after 19% stock plunge
CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.
The new missile Russia is using in Ukraine and why it has NATO on edge
Russia’s new intermediate-range ballistic missile has NATO members on edge after the missiles were used in a strike on Ukraine…
Timothée Chalamet: The 60 Minutes Interview
“A Complete Unknown” actor Timothée Chalamet, known for “Dune,” “Wonka,” and “Call Me By Your Name” grew up wary of…